Press Release
Dr. Joan Pfinsgraff Joins iJET Travel Intelligence as Director of Health Intelligence
Annapolis, Maryland - May 13, 2003 - iJET Travel Intelligence (iJET), the travel risk management
company, today announced that Dr. Joan Pfinsgraff, M.D. has joined the company
as Director of Health Intelligence. Dr. Pfinsgraff has overall responsibility
for iJET´s global health monitoring, including real-time notification of disease
outbreaks and other health-related concerns, and the continued growth of iJET´s
health intelligence databases. She will also serve as a member of iJET´s Health
Intelligence Board, an advisory panel consisting of experts in travel medicine,
infectious disease, epidemiology and tropical medicine.Dr. Pfinsgraff manages the aggregation and analysis of information from the Centers for Disease Control (CDC), the World Health Organization (WHO), many foreign national health services and hundreds of other sources to provide destination-specific health intelligence. Updated around the clock, seven days a week, iJET´s health intelligence provides travelers with timely information and advice, including immunization requirements and recommendations, disease incidence and risk factors, recommended preventative measures and information on obtaining medical assistance while traveling.
"Joan has been an invaluable member of the iJET team during the worldwide SARS outbreak, synthesizing voluminous and at times incomplete or even contradictory information to provide accurate, reliable and timely information to corporation decision markers and travelers," said Dr. Bradley A. Connor, Clinical Associate Professor of Medicine at Cornell University Medical College and Medical Director of The New York Center for Travel and Tropical Medicine. "iJET has set a new standard for evaluating and disseminating health information during this global outbreak."
"Our clients depend on real-time alerts and comprehensive special reports to better understand how changing conditions around the world may impact their operations and people overseas," said Bruce McIndoe, CEO of iJET. "Health-related threats pose greater risks to travelers than terrorism. We are committed to helping travelers avoid health problems through awareness and manage disruptions caused by disease outbreaks that they may encounter on the road."
Prior to joining iJET, Dr. Pfinsgraff served as a medical consultant in the pharmaceutical and biotech industries. During her eight-year tenure at DFM, Ltd., Dr. Pfinsgraff worked with pharmaceuticals, medical devices, and drug delivery systems in a variety of fields. Dr. Pfinsgraff is a graduate of Dartmouth Medical School. She completed her residency in internal medicine at Newton Wellesley Hospital in Boston and West Penn Hospital in Pittsburgh, where she also served as chief resident.
About iJET Intelligent Risk Systems
iJET Intelligent Risk Systems is a leader in business resiliency, helping multinational corporations and government organizations monitor, protect against and respond to global threats. Integrating world-class open source intelligence with patented technology, iJET’s award-winning Worldcue® solutions help clients monitor and assess global threats relative to their key people, facilities and supply chain assets; automatically track and communicate with travelers and expatriates; and deploy emergency response services throughout the world at a moment's notice. Providing a unified view of threats to assets, iJET enables clients to mitigate risks, reduce corporate liability and prepare for and respond to business disruptions.
